Table 9.
Phytochemical | Disease of Application | Mechanism of Action | References |
---|---|---|---|
Ascorbic acid | Cancer | Anti-inflammatory Antioxidant |
Jiménez et al. [21] |
Aging | Antioxidant and anti-inflammatory effect Contribution to skin and collagen formation |
Phetcharat et al. [181] | |
Arthritis rheumatoid | Inhibition of NO release from macrophages | Kirkeskov et al. [101] Kim et al. [111] Schwager et al. [108] |
|
Osteoporosis | Stimulation osteoblast differentiation and matrix synthesis | Devareddy et al. [124] Adom et al. [125] |
|
Polysaccharides | Cancer | Induction of cytotoxicity in reduction of cancer metastasis by reducing the levels of matrix metalloprotease-9 (MMP-9) | Guo et al. [96] Lee et al. [97] |
Polysaccharide-peptide complex and other polymers | Retroviral infection | Inhibition of viral retrotranscriptase | Fu et al. [212] |
Myricetin | Alzheimer | Inhibition of amyloid β formation and tau-antagonist activity | Semwal et al. [167] DeToma et al. [168] |
Quercetin | Age spots | Inhibition of tyrosinase | Fujii et al. [180] |
Gallic acid | Arthritis Rheumatoid | Reestablishment IκBα and NF-κB association | Choi et al. [116] |
Diabetes | Inhibition of α-amylase and α-glucosidase | Ghadyale et al. [138] | |
Ellagic acid | Cancer | Anti-mutagenic and anti-carcinogenic effect | Festa et al. [29] Whitley et al. [30] |
Bacterial infections | Downregulation of polyphosphatase kinase 1 (PPK1) | Sarabhai et al. [198] | |
Tellimagrandin I | Bacterial infections | Inhibition of penicillin binding protein 2′ (PBP2) and enhancement of β-lactam antibiotics effect | Shiota et al. [199] |
1,25-Dihydroxyvitamin D3 analogues | Acute myeloid leukemia | Induction of differentiation | Zhamanbayeva et al. [88] Corcoran et al. [89] Baurska et al. [90] |
Tannin RM-3 | Atopic dermatitis | Anti-inflammatory activity (reduction of the levels of cyclooxygenase 2 mediators and inducible nitric oxide synthase) Suppression Th2-polarized immune system |
Wang et al. [176] Park et al. [177] |
Unidentified phenols | Bacterial infections | Membrane permeabilisation, extracellular enzymes inhibition, nutrient and energy deprivation by an hyperacidification of plasma membrane interface that disrupts H+-ATPase | Olech et al. [195] |
Dysbiosis | Specific inhibition of pathogenic bacteria growth | Kamijo et al. [207] | |
Prostate cancer | Anti-histone acetyltransferase activity | Lee et al. [91] Takayama et al. [92] |
|
Urinary tract infections (UTIs) and pyelonephritis | Urease inhibitor | Hassan et al. [205] Bai et al. [204] |
|
Isoflavonoid phytoestrogen | Cancer | Stimulation of growing oestrogen dependent cells | Uifălean et al. [87] |
Flavonoids | Obesity | Reduction of PPARγ expression, and prevention of lipid accumulation | Ninomiya et al. [140] Nagatomo et al. [151] |
Epilepsy | Reduction of lipid peroxidation and anticonvulsive effect | Diniz et al. [170] Homayoun et al. [171] Uttara et al. [172] |
|
Triterpenoic acids, ursolic acid, oleanolic acid and betulinic acid | Arthritis Reumatoid | Inhibition of COX-1 and COX-2 | Jäger et al. [109] Wenzing et al. [110] |
Lycopene and other carotenes | Bacterial infections | Anti-H. pylori activity | Horváth et al. [200] |
trans-Tiliroside | Hyperlipidaemia | Reduction of reduced plasma and liver triglyceride free fatty acid (FFA) levels. Induction of peroxisome proliferator-activated receptor α (PPAR-α) expression |
Ninomiya et al. [140] |
Polyunsaturated fatty acid ω-3, 6 and 9 | Hyperlipidaemia | Reduction of TG synthesis, reduction of the expression of hepatic very low-density lipoprotein (VLDL)-TG, hepatic lipase and Apo CIII and increase Apo CII and VLDL-receptor | Adkins et al. [144] |
Galactolipids GOPO (1,2-di-O-α-linolenoyl-3-O-β-d-galactopyranosyl-sn-glycerol) |
Arthritis Rheumatoid | Reduction in peripheral blood polymorphonuclear leukocytes, neutrophils and monocytes migration Reduction in the levels of C-reactive protein (CRP) |
Larsen et al. [61] Kharazmi et al. [102] Whinter et al. [105] |
Unidentified compounds from whole extract | Arthritis rheumatoid | Inhibition of RANKL-induced osteoclastogenesis | Cheng et al. [120] |
Diabetes | Hypoglycemic effect and induction of β-cell proliferation | Taghizadeh et al. [134] Fattahi et al. [137] |
|
Acute kidney injury Diabetic nephropathy |
Anti-inflammatory effect Reduction of ROS levels |
Zhao et al. [155] Zhou et al. [157] |
|
Peptic ulcer | Antioxidant effect | Nazıroğlu et al. [175] | |
Depression | Antioxidant effect | Nazıroğlu et al. [175] | |
Antiviral | Inhibition of viral invasion capacity | McCutcheon et al. [65] | |
Unidentified components from fruit extract | Hepatic injuries | Reduction of peroxidation of unsaturated fatty acids | Carlo et al. [187] Meli et al. [188] |
Unidentified components from root extract | Atopic dermatitis | Anti-inflammatory (reduction of cyclooxygenase 2 inducible nitric oxide synthase levels) Suppression Th2-polarized immune system |
Park et al. [177] |
Unidentified components from leaf extract | Diarrhoeal | Anti-secretory activity, inhibition of acetylcholine and histamine activity | Carlo et al. [187] Meli et al. [188] Rao et al. [186] |
Unidentified components from rose powder | Wrinkles | Antioxidant effect: scavenging of reactive oxygen species produced by UV-radiation and decrease of matrix metalloprotease proteins levels | Phetcharat et al. [181] Jeo et al. [183] |